Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta blockers in heart insufficiency]

G Noll1

  • 1Departement Medizin, Universitätsklinik Bern.

Praxis
|March 14, 1995
PubMed
Summary
This summary is machine-generated.

Beta blockers may not reduce mortality in congestive heart failure patients, but they can improve symptoms and hemodynamics, especially in those with congestive cardiomyopathy. Further research is needed for routine use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome.

International journal of cardiology·2016
Same author

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Der Internist·2014
Same author

The antiproliferative effect of pinostrobin on human umbilical vein endothelial cells (HUVEC).

European review for medical and pharmacological sciences·2013
Same author

Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care.

International journal of clinical practice·2012
Same author

[Effect of paracetamol (acetaminophen) on blood pressure in patients with coronary heart disease].

Praxis·2012
Same author

[Heart failure. 2: Therapy].

Praxis·2010
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Congestive heart failure (CHF) is a prevalent condition.
  • Prognosis in CHF is linked to neurohumoral system activation.

Purpose:

  • To evaluate the role of beta-blocking agents in managing congestive heart failure.
  • To assess the impact of beta blockers on mortality, clinical course, symptoms, and hemodynamic parameters in CHF patients.

Summary:

  • Beta blockers did not reduce mortality in reviewed studies.
  • Positive effects were observed on clinical course, symptoms, and hemodynamics, particularly in congestive cardiomyopathy.
  • Further research is required to confirm specific advantages for routine CHF therapy.

Impact:

  • Beta blockers show potential benefits in managing CHF symptoms and hemodynamics.

Related Experiment Videos

  • Evidence suggests a specific benefit in congestive cardiomyopathy patients.
  • Definitive recommendations for routine beta blocker therapy in heart failure await further investigation.